Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pascal Schmitt is active.

Publication


Featured researches published by Pascal Schmitt.


Biochemical and Biophysical Research Communications | 1988

N-acylated pentapeptides antagonists of substance P on guinea-pig ileum.

Pascal Schmitt; Michel Mayer; Sylviane Magneney; Robert Michelot; Pierre Potier

Summary Pentapeptides X-D,Trp-Phe-D.Trp-Leu-Y-NH2 (X = H, Boc, parachydroxyphenylacetyl, Y = Met,Leu,Nle,Phe) were tested as antagonists against Substance P and against a specific agonist of the muscular receptor of neurokinins on the guinea-pig ileum . Weak antagonist or agonist activities could be observed with the free or the Boc-protected pentapeptides whilst the acylated compounds could be compared favorably with the best antagonists already described.


European Journal of Medicinal Chemistry | 1988

Activity of the C-terminal part of substance P on guinea pig ileum and trachea preparations I. N-acylated pentapeptides SP(7–11)

Robert Michelot; Michel Mayer; Sylviane Magneney; Paul Pham Van Chuong; Pascal Schmitt; Pierre Potier

Abstract Acylated pentapeptide XPhePheGlyLeuMetNH2 analogs of the substance P (7–11) sequence were synthesized by solution method and their spasmogenic activities were evaluated on guinea pig ileum (GPI) and trachea (GPT). Pentapeptide SP(7–11) had the lowest potency and its N-acylation increased its activity in both tests, with some derivatives being more active than SP itself. Results obtained on GPI suggest a close dependence of activity upon structural factors in the vicinity of the Phe7 N-terminus, whereas the activity on GPT seems more dependent upon the hydrophobicity of the analogs.


European Journal of Medicinal Chemistry | 1991

Synthesis and biological activities of neurokinin pseudopeptide analogues containing a reduced peptide bond

D Jukic; Michel Mayer; Pascal Schmitt; G Drapeau; Domenico Regoli; Robert Michelot

A series of pseudopeptides, analogues of neurokinin selective agonists, in which a peptide bond was replaced by a (CH2NH) bond were synthesized. The biological activities of these compounds were determined on selective pharmacological preparations: the dog carotid artery for NK-1, the rabbit pulmonary artery devoid of endothelium for the NK-2 and the rat portal vein for the NK-3 receptors. The results reported in this study indicate that insertion of a pseudopeptide bond in various positions of these selective agonists resulted in a great decrease in potency compared to the parent compounds. Furthermore, the selectivity of agonists is maintained by the use of a methylene amino group in position 9–10 (Sar) for the NK-1 or in position 7–8 (MePhe) for the NK-3 selective compound. The selectivity is greatly diminished for the NK-2 analogues.


Regulatory Peptides | 1988

N-acylated pentapeptides antagonists of substance P on guinea-pig ileum

Robert Michelot; Michel Mayer; Pascal Schmitt; Sylviane Magneney; Pierre Potier

Pentapeptides X-D.Trp-Phe-D.Trp-Leu-Y-NH2 (X = H, Boc, parahydroxyphenylacetyl, Y = Met,Leu,Nle,Phe) were tested as antagonists against Substance P and against a specific agonist of the muscular receptor of neurokinins on the guinea-pig ileum. Weak antagonist or agonist activities could be observed with the free or the Boc-protected pentapeptides whilst the acylated compounds could be compared favorably with the best antagonists already described.


Archive | 1994

Eburnane derivatives, processes for their preparation and pharmaceutical compositions containing them

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-François Pujol; Pascal Schmitt; Pierre Potier


Archive | 1994

Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-Fran Ois Pujol; Pascal Schmitt; Pierre Potier


Archive | 1994

Eburnan analogs; process for preparing the same and pharmaceutical compositions containing them

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-François Pujol; Pascal Schmitt; Pierre Potier


Archive | 1994

Eburnan-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen Eburnan derivatives, process for their preparation and pharmaceutical compositions containing them

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-François Pujol; Pascal Schmitt; Pierre Potier


Archive | 1994

Eburnan derivatives, process for the preparation of such derivatives and pharmaceutical compositions containing them

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-Fran Ois Pujol; Pascal Schmitt; Pierre Potier


Archive | 1994

Eburnan derivatives, processes for their preparation and pharmaceutical compositions containing them

Jean-Daniel Brion; Claude Thal; Luc Demuynck; Jean-Gilles Parmentier; Jean Lepagnol; Pierre Lestage; Jean-François Pujol; Pascal Schmitt; Pierre Potier

Collaboration


Dive into the Pascal Schmitt's collaboration.

Top Co-Authors

Avatar

Pierre Potier

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Claude Thal

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

Luc Demuynck

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

Jean-Daniel Brion

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Michel Mayer

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

Robert Michelot

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

Sylviane Magneney

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

Paul Pham Van Chuong

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar

D Jukic

Université de Sherbrooke

View shared research outputs
Top Co-Authors

Avatar

G Drapeau

Université de Sherbrooke

View shared research outputs
Researchain Logo
Decentralizing Knowledge